When Melissa discovered the lump in her breast just three months after having a mammogram, she immediately went to her doctor. She credits the physicians at Lexington Oncology for her survival. After a double mastectomy, radiation and chemotherapy, Melissa is grateful to be cancer-free and wants to stay that way.
After going through this life-changing experience, she told her team at Lexington Oncology "Anything and everything I can do to help prevent this or help people get through this, I want to do it."
Melissa was chosen to participate in two clinical trials at Lexington Medical Center - one for the effectiveness of a targeted therapy called Ibrance in patients with stage 2 or stage 3 cancer. The other trial involves the use of aspirin in patients who have had cancer.
As a participant in these clinical trials, Melissa will be followed for 10 years. She hopes to remain cancer-free.
222 East Medical Lane